Argan, Inc. to Announce First Quarter Fiscal 2027 Results and Host Conference Call on Thursday, June 4, 2026

Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its first quarter fiscal 2027 financial results after the market closes on Thursday, June 4, 2026. Management will host a webcast with an accompanying slide presentation and conference call on Thursday, June 4, 2026 at 5:00 p.m. ET. Participants can [...]

LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, Fla. Vladimir Makatsaria, Chief Executive Officer of LivaNova; Alex Shvartsburg, Chief Financial Officer; and Phil Kowalczyk, Chief Strategy and Corporate Development Officer, will participate in a fireside chat on…

ReNew Announces Results for the Fourth Quarter and Full Fiscal Year: Reports Highest Ever Net Profit

Net Profit jumped 2.3x during the year ended March 31, 2026 Increase in net profit driven by higher operating portfolio, lower leverage and growth in manufacturing business Commissioned 2.4GW of capacity, its highest ever, during the year ended March 31, 2026

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of Silence Therapeutics, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday, May 19, 2026 at 2:00 p.m. ET. The live webcast can be [...]

Prothena Reports First Quarter 2026 Financial Results and Business Highlights

Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected full year 2026 net cash used in operating and investing actives to be $18 to $23 million (versus prior guidance $50 to $55 million) and expects to end the year with approximately $273 million (midpoint)…

Read more →
Arm Holdings plc Reports Results for the Fourth Quarter and Fiscal Year Ended 2026

Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has today published a letter to its shareholders containing the company’s results for its fourth quarter and fiscal year ended March 31, 2026. The letter is available on its investor relations website (https://investors.arm.com/financials/quarterly-annual-results). The shareholder letter will also be furnished…

Allegion (NYSE: ALLE) Reports Q1-2026 Financial Results

High-Single Digit Revenue Growth for the Enterprise; Affirming FY-2026 Organic Revenue Outlook Quarterly Financial Highlights (All comparisons are year-over-year, unless otherwise noted) Net earnings per share (EPS) of $1.59, down 7.0% compared with $1.71; Adjusted EPS of $1.80, down 3.2% compared with $1.86 Revenues of $1,033.6 million, up 9.7% on a reported basis and up 2.6% on an organic basis…

Read more →
Janus Henderson to Report First Quarter 2026 Results

Janus Henderson Group plc (NYSE: JHG) (“Janus Henderson” or the “Company”) will announce its first quarter 2026 results after market close on Friday, May 8, 2026. While the previously announced take-private transaction with Trian Fund Management, L.P. and its affiliated funds, and General Catalyst Group Management, LLC and its affiliated funds remains pending, the Company [...]

New WP Engine AI Agency Trends Report Finds the Rise of the Intelligent Web is Accelerating Digital Agency Investment in AI

With the emergence of web design tailored for both humans and AI agents, 63% of agencies are investing in AI tools and platforms, while 72% have adjusted development and design practices, signaling a shift in the digital agency model

Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The announcement will be followed by [...]

Allegion to Attend 2026 Barclays Industrial Select Conference

Allegion plc (NYSE: ALLE) President and CEO John H. Stone will discuss the company’s long-term strategy at the 2026 Barclays Industrial Select Conference on Thursday, Feb. 19. The conference will be held at Loews Miami Beach Hotel. A live listen-only webcast will be accessible via Allegion’s investor website at investor.allegion.com or directly by clicking here. [...]

Luxfer Announces Date of Fourth Quarter and Full Year 2025 Earnings Conference Call

Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications in materials engineering, today announced the details for its fourth quarter and full-year 2025 earnings conference call. Date and time: Wednesday, February 25, 2026, at 8:30 a.m. Eastern Time Luxfer participants: Andy Butcher Chief Executive Officer Steve Webster [...]

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026

Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company’s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company. The webcast player and accompanying [...]

Page 1